Darwin Global Management, Ltd.
13F holdings for Q2 2026 · ST. HELIER, Y9 · filed August 14, 2026
Darwin Global Management, Ltd. reported $3.8B in 13F securities across 5 holdings for Q2 2026, in a Form 13F filed August 14, 2026. The largest positions were RVMD (54.5%), INSM (17.9%), BLTE (12.1%). Reported value fell 0.3% from the quarter before. It opened 0 new positions, added to 3, trimmed 2 and sold out of 1.
- 13F value Q2 2026
- $3.8B
- Holdings
- 5
- Change vs prior quarter
- -0.3%
- Rank by 13F value
- #1,088
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Top holdings
| Stock | Value | Weight | Shares | Change in shares | Move |
|---|---|---|---|---|---|
| RVMD Revolution Medicines Inc. | $2.0B | 54.5% | 10,629,822 | +380.8% | Added |
| INSM Insmed Incorporated | $674M | 17.9% | 6,431,163 | -61.7% | Trimmed |
| BLTE Belite Bio Inc | $457M | 12.1% | 3,077,219 | +0.6% | Added |
| ABVX Abivax SA | $348M | 9.3% | 3,621,583 | +4.4% | Added |
| Roivant Sciences LTD SHS | $234M | 6.2% | 6,747,300 | -0.7% | Trimmed |
Share positions only, at the value reported for the end of Q2 2026. Weight is the share of $3.8B in share positions; options and bonds count in the 13F value but not here.
Biggest buys in Q2 2026
- RVMD Revolution Medicines Inc. Added+$1.6B
- ABVX Abivax SA Added+$14.7M
- BLTE Belite Bio Inc Added+$2.9M
Biggest sells in Q2 2026
- INSM Insmed Incorporated Trimmed-$1.1B
- Roivant Sciences LTD SHS Trimmed-$1.7M
- DNTH Dianthus Therapeutics Inc. Sold out-$1.5M
The change in shares since Q1 2026, adjusted for stock splits and priced at the Q2 2026 value per share. 0 new, 3 added, 2 trimmed, 1 sold out.
Sector mix
- Health Care93.8%
- Not listed with us6.2%
13F value by quarter
Schedule 13D and 13G filings by Darwin Global Management, Ltd.
Stakes above 5% of a company, filed within days rather than once a quarter.
- 2025-12-10BLTE SCHEDULE 13G filed by Belite Bio IncSchedule 13G
Questions about Darwin Global Management, Ltd.
- What does Darwin Global Management, Ltd. own?
- In its Form 13F for Q2 2026, Darwin Global Management, Ltd. reported 5 holdings worth $3.8B. The five largest were RVMD, INSM, BLTE, ABVX, Roivant Sciences LTD SHS.
- What did Darwin Global Management, Ltd. buy and sell in Q2 2026?
- Darwin Global Management, Ltd. opened 0 new positions, added to 3, trimmed 2 and sold out of 1 compared with the quarter before.
- When did Darwin Global Management, Ltd. file its latest 13F?
- Form 13F is due 45 days after each quarter ends. The Q2 2026 report was due August 14, 2026 and was filed August 14, 2026.
From Form 13F filed by Darwin Global Management, Ltd. (SEC CIK 0001839209) for the quarter ended June 30, 2026, via the SEC's Form 13F data sets. Amendments that restate a report replace it; amendments that add holdings are included. View on SEC EDGAR · All funds · Get this as JSON